Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Waerner, T; Gardellin, P; Pfizenmaier, K; Weith, A; Kraut, N
   Human RERE is localized to nuclear promyelocytic leukemia oncogenic domains and enhances apoptosis
   CELL GROWTH & DIFFERENTIATION
   
   T. Waerner et al., "Human RERE is localized to nuclear promyelocytic leukemia oncogenic domains and enhances apoptosis", CELL GROWTH, 12(4), 2001, pp. 201-210
2. Wilkins, JF; Haig, D
   Genomic imprinting of two antagonistic loci
   PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
   
   J.F. Wilkins e D. Haig, "Genomic imprinting of two antagonistic loci", P ROY SOC B, 268(1479), 2001, pp. 1861-1867
3. Zelent, A; Guidez, F; Melnick, A; Waxman, S; Licht, JD
   Translocations of the RAR alpha gene in acute promyelocytic leukemia
   ONCOGENE
   
   A. Zelent et al., "Translocations of the RAR alpha gene in acute promyelocytic leukemia", ONCOGENE, 20(49), 2001, pp. 7186-7203
4. Negorev, D; Maul, GG
   Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot
   ONCOGENE
   
   D. Negorev e G.G. Maul, "Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot", ONCOGENE, 20(49), 2001, pp. 7234-7242
5. Lallemand-Breitenbach, V; Zhu, J; de The, H
   Promyelocytic leukemia, a unique model to design treatments targeting oncogenes
   M S-MEDECINE SCIENCES
   
   V. Lallemand-Breitenbach et al., "Promyelocytic leukemia, a unique model to design treatments targeting oncogenes", M S-MED SCI, 17(1), 2001, pp. 14-22
6. Mizuguchi, M; Takashima, S
   Neuropathology of tuberous sclerosis
   BRAIN & DEVELOPMENT
   
   M. Mizuguchi e S. Takashima, "Neuropathology of tuberous sclerosis", BRAIN DEVEL, 23(7), 2001, pp. 508-515
7. Kawano, Y; Sasaki, M; Nakahira, K; Yoshimine, T; Shimizu, K; Wada, H; Ikenaka, K
   Structural characterization and chromosomal localization of the MAGE-E1 gene
   GENE
   
   Y. Kawano et al., "Structural characterization and chromosomal localization of the MAGE-E1 gene", GENE, 277(1-2), 2001, pp. 129-137
8. Matsumoto, K; Taniura, H; Uetsuki, T; Yoshikawa, K
   Necdin acts as a transcriptional repressor that interacts with multiple guanosine clusters
   GENE
   
   K. Matsumoto et al., "Necdin acts as a transcriptional repressor that interacts with multiple guanosine clusters", GENE, 272(1-2), 2001, pp. 173-179
9. Stone, B; Schummer, M; Paley, PJ; Crawford, M; Ford, M; Urban, N; Nelson, BH
   MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily
   GENE
   
   B. Stone et al., "MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily", GENE, 267(2), 2001, pp. 173-182
10. Wataya-Kaneda, M; Kaneda, Y; Hino, O; Adachi, H; Hirayama, Y; Seyama, K; Satou, T; Yoshikawa, K
    Cells derived from tuberous sclerosis show a prolonged S phase of the cellcycle and increased apoptosis
    ARCHIVES OF DERMATOLOGICAL RESEARCH
    
    M. Wataya-Kaneda et al., "Cells derived from tuberous sclerosis show a prolonged S phase of the cellcycle and increased apoptosis", ARCH DERM R, 293(9), 2001, pp. 460-469
11. Becker, AJ; Lobach, M; Klein, H; Normann, S; Nothen, MM; von Deimling, A; Mizuguchi, M; Elger, CE; Schramm, J; Wiestler, OD; Blumcke, I
    Mutational analysis of TSC1 and TSC2 genes in gangliogliomas
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    
    A.J. Becker et al., "Mutational analysis of TSC1 and TSC2 genes in gangliogliomas", NEUROP AP N, 27(2), 2001, pp. 105-114
12. Regad, T; Saib, A; Lallemand-Breitenbach, V; Pandolfi, PP; de The, H; Chelbi-Alix, MK
    PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator
    EMBO JOURNAL
    
    T. Regad et al., "PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator", EMBO J, 20(13), 2001, pp. 3495-3505
13. Hobbs, WE; Brough, DE; Kovesdi, I; DeLuca, NA
    Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival
    JOURNAL OF VIROLOGY
    
    W.E. Hobbs et al., "Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival", J VIROLOGY, 75(7), 2001, pp. 3391-3403
14. Djavani, M; Rodas, J; Lukashevich, IS; Horejsh, D; Pandolfi, PP; Borden, KLB; Salvato, MS
    Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus
    JOURNAL OF VIROLOGY
    
    M. Djavani et al., "Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus", J VIROLOGY, 75(13), 2001, pp. 6204-6208
15. Catania, MG; Mischel, PS; Vinters, HV
    Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    
    M.G. Catania et al., "Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B", J NE EXP NE, 60(7), 2001, pp. 711-723
16. Masuda, Y; Sasaki, A; Shibuya, H; Ueno, N; Ikeda, K; Watanabe, K
    Dlxin-1, a novel protein that binds D1x5 and regulates its transcriptionalfunction
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    Y. Masuda et al., "Dlxin-1, a novel protein that binds D1x5 and regulates its transcriptionalfunction", J BIOL CHEM, 276(7), 2001, pp. 5331-5338
17. Forslund, KO; Nordqvist, K
    The melanoma antigen genes - Any clues to their functions in normal tissues?
    EXPERIMENTAL CELL RESEARCH
    
    K.O. Forslund e K. Nordqvist, "The melanoma antigen genes - Any clues to their functions in normal tissues?", EXP CELL RE, 265(2), 2001, pp. 185-194
18. Ababneh, M; Gotz, C; Montenarh, M
    Downregulation of the cdc2/cyclin B protein kinase activity by binding of p53 to p34(cdc2)
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    M. Ababneh et al., "Downregulation of the cdc2/cyclin B protein kinase activity by binding of p53 to p34(cdc2)", BIOC BIOP R, 283(2), 2001, pp. 507-512
19. Niida, Y; Stemmer-Rachamimov, AO; Logrip, M; Tapon, D; Perez, R; Kwiatkowski, DJ; Sims, K; MacCollin, M; Louis, DN; Ramesh, V
    Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomassuggests different genetic mechanisms for pathogenesis of TSC lesions
    AMERICAN JOURNAL OF HUMAN GENETICS
    
    Y. Niida et al., "Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomassuggests different genetic mechanisms for pathogenesis of TSC lesions", AM J HU GEN, 69(3), 2001, pp. 493-503
20. Murthy, V; Stemmer-Rachamimov, AO; Haddad, LA; Roy, JE; Cutone, AN; Beauchamp, RL; Smith, N; Louis, DN; Ramesh, V
    Developmental expression of the tuberous sclerosis proteins tuberin and hamartin
    ACTA NEUROPATHOLOGICA
    
    V. Murthy et al., "Developmental expression of the tuberous sclerosis proteins tuberin and hamartin", ACT NEUROP, 101(3), 2001, pp. 202-210
21. Zhong, S; Salomoni, P; Pandolfi, PP
    The transcriptional role of PML and the nuclear body
    NATURE CELL BIOLOGY
    
    S. Zhong et al., "The transcriptional role of PML and the nuclear body", NAT CELL BI, 2(5), 2000, pp. E85-E90
22. Vannucchi, S; Percario, ZA; Chiantore, MV; Matarrese, P; Chelbi-Alix, MK; Fagioli, M; Pelicci, PG; Malorni, W; Fiorucci, G; Romeo, G; Affabris, E
    Interferon-beta induces S phase slowing via up-regulated expression of PMLin squamous carcinoma cells
    ONCOGENE
    
    S. Vannucchi et al., "Interferon-beta induces S phase slowing via up-regulated expression of PMLin squamous carcinoma cells", ONCOGENE, 19(44), 2000, pp. 5041-5053
23. Niinobe, M; Koyama, K; Yoshikawa, K
    Cellular and subcellular localization of necdin in fetal and adult mouse brain
    DEVELOPMENTAL NEUROSCIENCE
    
    M. Niinobe et al., "Cellular and subcellular localization of necdin in fetal and adult mouse brain", DEV NEUROSC, 22(4), 2000, pp. 310-319
24. Nakada, Y; Taniura, H; Uetsuki, T; Yoshikawa, K
    Characterization and chromosomal mapping of a human necdin pseudogene
    GENE
    
    Y. Nakada et al., "Characterization and chromosomal mapping of a human necdin pseudogene", GENE, 245(1), 2000, pp. 185-191
25. Murthy, V; Haddad, LA; Smith, N; Pinney, D; Tyszkowski, R; Brown, D; Ramesh, V
    Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
    
    V. Murthy et al., "Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney", AM J P-REN, 278(5), 2000, pp. F737-F746
26. Ruggero, D; Wang, ZG; Pandolfi, PP
    The puzzling multiple lives of PML and its role in the genesis of cancer
    BIOESSAYS
    
    D. Ruggero et al., "The puzzling multiple lives of PML and its role in the genesis of cancer", BIOESSAYS, 22(9), 2000, pp. 827-835
27. Yoshikawa, K
    Cell cycle regulators in neural stem cells and postmitotic neurons
    NEUROSCIENCE RESEARCH
    
    K. Yoshikawa, "Cell cycle regulators in neural stem cells and postmitotic neurons", NEUROSCI RE, 37(1), 2000, pp. 1-14
28. Folpe, AL; Goodman, ZD; Ishak, KG; Paulino, AFG; Taboada, EM; Meehan, SA; Weiss, SW
    Clear cell myomelanocytic tumor of the falciform ligament/ligamentum teres- A novel member of the perivascular epithelioid clear cell family of tumors with a predilection for children and young adults
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    
    A.L. Folpe et al., "Clear cell myomelanocytic tumor of the falciform ligament/ligamentum teres- A novel member of the perivascular epithelioid clear cell family of tumors with a predilection for children and young adults", AM J SURG P, 24(9), 2000, pp. 1239-1246
29. Ahn, JH; Hayward, GS
    Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection
    VIROLOGY
    
    J.H. Ahn e G.S. Hayward, "Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection", VIROLOGY, 274(1), 2000, pp. 39-55
30. Carsillo, T; Astrinidis, A; Henske, EP
    Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    T. Carsillo et al., "Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis", P NAS US, 97(11), 2000, pp. 6085-6090
31. Mizuguchi, M; Takashima, S; Yamanouchi, H; Nakazato, Y; Mitani, H; Hino, O
    Novel cerebral lesions in the Eker rat model of tuberous sclerosis: Cortical tuber and anaplastic ganglioglioma
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    
    M. Mizuguchi et al., "Novel cerebral lesions in the Eker rat model of tuberous sclerosis: Cortical tuber and anaplastic ganglioglioma", J NE EXP NE, 59(3), 2000, pp. 188-196
32. Zhang, P; Chin, W; Chow, LTC; Chan, ASK; Yim, APC; Leung, SF; Mok, TSK; Chang, KS; Johnson, PJ; Chan, JYH
    Lack of expression for the suppressor PML in human small cell lung carcinoma
    INTERNATIONAL JOURNAL OF CANCER
    
    P. Zhang et al., "Lack of expression for the suppressor PML in human small cell lung carcinoma", INT J CANC, 85(5), 2000, pp. 599-605
33. Hennuy, B; Reiter, E; Cornet, A; Bruyninx, M; Daukandt, M; Houssa, P; N'Guyen, VH; Closset, J; Hennen, G
    A novel messenger ribonucleic acid homologous to human MAGE-D is strongly expressed in rat Sertoli cells and weakly in Leydig cells and is regulated by follitropin, lutropin, and prolactin
    ENDOCRINOLOGY
    
    B. Hennuy et al., "A novel messenger ribonucleic acid homologous to human MAGE-D is strongly expressed in rat Sertoli cells and weakly in Leydig cells and is regulated by follitropin, lutropin, and prolactin", ENDOCRINOL, 141(10), 2000, pp. 3821-3831
34. Kogan, SC; Hong, SH; Shultz, DB; Privalsky, ML; Bishop, JM
    Leukemia initiated by PMLRAR alpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable
    BLOOD
    
    S.C. Kogan et al., "Leukemia initiated by PMLRAR alpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable", BLOOD, 95(5), 2000, pp. 1541-1550
35. El-Husseini, AED; Kwasnicka, D; Yamada, T; Hirohashi, S; Vincent, SR
    BERP, a novel ring finger protein, binds to alpha-actinin-4
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    A.E.D. El-Husseini et al., "BERP, a novel ring finger protein, binds to alpha-actinin-4", BIOC BIOP R, 267(3), 2000, pp. 906-911
36. Mizuguchi, M; Ikeda, K; Takashima, S
    Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis
    ACTA NEUROPATHOLOGICA
    
    M. Mizuguchi et al., "Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis", ACT NEUROP, 99(5), 2000, pp. 503-510
37. Suzuki, M; Watanabe, TK; Fujiwara, T; Nakamura, Y; Takahashi, E; Tanigami, A
    Molecular cloning, expression, and mapping of a novel human cDNA, GRP17, highly homologous to human gadd45 and murine MyD118
    JOURNAL OF HUMAN GENETICS
    
    M. Suzuki et al., "Molecular cloning, expression, and mapping of a novel human cDNA, GRP17, highly homologous to human gadd45 and murine MyD118", J HUM GENET, 44(5), 1999, pp. 300-303
38. Gerard, M; Hernandez, L; Wevrick, R; Stewart, CL
    Disruption of the mouse necdin gene results in early post-natal lethality
    NATURE GENETICS
    
    M. Gerard et al., "Disruption of the mouse necdin gene results in early post-natal lethality", NAT GENET, 23(2), 1999, pp. 199-202
39. Johnson, MW; Emelin, JK; Park, SH; Vinters, HV
    Co-localization of TSC1 and TSG2 gene products in tubers of patients with tuberous sclerosis
    BRAIN PATHOLOGY
    
    M.W. Johnson et al., "Co-localization of TSC1 and TSG2 gene products in tubers of patients with tuberous sclerosis", BRAIN PATH, 9(1), 1999, pp. 45-54
40. Chelbi-Alix, MK; de The, H
    Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins
    ONCOGENE
    
    M.K. Chelbi-Alix e H. de The, "Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins", ONCOGENE, 18(4), 1999, pp. 935-941
41. Koken, MHM; Daniel, MT; Gianni, M; Zelent, A; Licht, J; Buzyn, A; Minard, P; Degos, L; Varet, B; de The, H
    Retinoic acid, but not arsenic trioxide, degrades the PLZF/RAR alpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient
    ONCOGENE
    
    M.H.M. Koken et al., "Retinoic acid, but not arsenic trioxide, degrades the PLZF/RAR alpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient", ONCOGENE, 18(4), 1999, pp. 1113-1118
42. Kogan, SC; Bishop, JM
    Acute promyelocytic leukemia: from treatment to genetics and back
    ONCOGENE
    
    S.C. Kogan e J.M. Bishop, "Acute promyelocytic leukemia: from treatment to genetics and back", ONCOGENE, 18(38), 1999, pp. 5261-5267
43. Plank, TL; Logginidou, H; Klein-Szanto, A; Henske, EP
    The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas
    MODERN PATHOLOGY
    
    T.L. Plank et al., "The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas", MOD PATHOL, 12(5), 1999, pp. 539-545
44. Chelbi-Alix, MK; Pelicano, L
    Retinoic acid and interferon signaling cross talk in normal and RA-resistant APL cells
    LEUKEMIA
    
    M.K. Chelbi-Alix e L. Pelicano, "Retinoic acid and interferon signaling cross talk in normal and RA-resistant APL cells", LEUKEMIA, 13(8), 1999, pp. 1167-1174
45. Vinters, HV; Park, SH; Johnson, MW; Mischel, PS; Catania, M; Kerfoot, C
    Cortical dysplasia, genetic abnormalities and neurocutaneous syndromes
    DEVELOPMENTAL NEUROSCIENCE
    
    H.V. Vinters et al., "Cortical dysplasia, genetic abnormalities and neurocutaneous syndromes", DEV NEUROSC, 21(3-5), 1999, pp. 248-259
46. Benninghoff, J; Kartarius, S; Teleb, Z; Selter, H; Unteregger, G; Zwergel, T; Wullich, B; Montenarh, M
    Two different forms of p53 localized differently within cells of urogenital tumours
    CANCER LETTERS
    
    J. Benninghoff et al., "Two different forms of p53 localized differently within cells of urogenital tumours", CANCER LETT, 144(1), 1999, pp. 55-64
47. Selter, H; Schmidt, G; Villena-Heinsen, C; Montenarh, M
    Humoral immune response to p21(WAF1/CIP1) tumor patients, non-tumorous patients and healthy blood donors
    CANCER LETTERS
    
    H. Selter et al., "Humoral immune response to p21(WAF1/CIP1) tumor patients, non-tumorous patients and healthy blood donors", CANCER LETT, 137(2), 1999, pp. 151-157
48. Gotz, C; Scholtes, P; Prowald, A; Schuster, N; Nastainczyk, W; Montenarh, M
    Protein kinase CK2 interacts with a multi-protein binding domain of p53
    MOLECULAR AND CELLULAR BIOCHEMISTRY
    
    C. Gotz et al., "Protein kinase CK2 interacts with a multi-protein binding domain of p53", MOL C BIOCH, 191(1-2), 1999, pp. 111-120
49. Zhu, J; Gianni, M; Kopf, E; Honore, N; Chelbi-Alix, M; Koken, M; Quignon, F; Rochette-Egly, C; de The, H
    Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RAR alpha) and oncogenic RAR alpha fusion proteins
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    J. Zhu et al., "Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RAR alpha) and oncogenic RAR alpha fusion proteins", P NAS US, 96(26), 1999, pp. 14807-14812
50. Lallemand-Breitenbach, V; Guillemin, MC; Janin, A; Daniel, MT; Degos, L; Kogan, SC; Bishop, JM; de The, H
    Retinoic acid and arsenic synergize to eradicate leukemic cells in a mousemodel of acute promyelocytic leukemia
    JOURNAL OF EXPERIMENTAL MEDICINE
    
    V. Lallemand-Breitenbach et al., "Retinoic acid and arsenic synergize to eradicate leukemic cells in a mousemodel of acute promyelocytic leukemia", J EXP MED, 189(7), 1999, pp. 1043-1052
51. Guldner, HH; Szostecki, C; Schroder, P; Matschl, U; Jensen, K; Luders, C; Will, H; Sternsdorf, T
    Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif
    JOURNAL OF CELL SCIENCE
    
    H.H. Guldner et al., "Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif", J CELL SCI, 112(5), 1999, pp. 733-747
52. Kao, CY; Tanimoto, A; Arima, N; Sasaguri, Y; Padmanabhan, R
    Transactivation of the human cdc2 promoter by adenovirus E1A - E1A inducesthe expression and assembly of a heteromeric complex consisting of the CCAAT box binding factor, CBF/NF-Y, and a 110-kDa DNA-binding protein
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    C.Y. Kao et al., "Transactivation of the human cdc2 promoter by adenovirus E1A - E1A inducesthe expression and assembly of a heteromeric complex consisting of the CCAAT box binding factor, CBF/NF-Y, and a 110-kDa DNA-binding protein", J BIOL CHEM, 274(33), 1999, pp. 23043-23051
53. Sternsdorf, T; Jensen, K; Reich, B; Will, H
    The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    T. Sternsdorf et al., "The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers", J BIOL CHEM, 274(18), 1999, pp. 12555-12566
54. Schuster, N; Prowald, A; Schneider, E; Scheidtmann, KH; Montenarh, M
    Regulation of p53 mediated transactivation by the beta-subunit of protein kinase CK2
    FEBS LETTERS
    
    N. Schuster et al., "Regulation of p53 mediated transactivation by the beta-subunit of protein kinase CK2", FEBS LETTER, 447(2-3), 1999, pp. 160-166
55. Du, CC; Redner, RL; Cooke, MP; Lavau, C
    Overexpression of wild-type retinoic acid receptor alpha (RAR alpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RAR alpha-fusion genes
    BLOOD
    
    C.C. Du et al., "Overexpression of wild-type retinoic acid receptor alpha (RAR alpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RAR alpha-fusion genes", BLOOD, 94(2), 1999, pp. 793-802
56. YOUNG J; POVEY S
    THE GENETIC-BASIS OF TUBEROUS SCLEROSIS
    Molecular medicine today
    
    J. Young e S. Povey, "THE GENETIC-BASIS OF TUBEROUS SCLEROSIS", Molecular medicine today, 4(7), 1998, pp. 313-319
57. QUIGNON F; DEBELS F; KOKEN M; FEUNTEUN J; AMEISEN JC; DETHE H
    PML INDUCES A NOVEL CASPASE-INDEPENDENT DEATH PROCESS
    Nature genetics
    
    F. Quignon et al., "PML INDUCES A NOVEL CASPASE-INDEPENDENT DEATH PROCESS", Nature genetics, 20(3), 1998, pp. 259-265
58. GABOLI M; GANDINI D; DELVA L; WANG ZG; PANDOLFI PP
    ACUTE PROMYELOCYTIC LEUKEMIA AS A MODEL FOR CROSS-TALK BETWEEN INTERFERON AND RETINOIC ACID PATHWAYS - FROM MOLECULAR-BIOLOGY TO CLINICAL-APPLICATIONS
    Leukemia & lymphoma
    
    M. Gaboli et al., "ACUTE PROMYELOCYTIC LEUKEMIA AS A MODEL FOR CROSS-TALK BETWEEN INTERFERON AND RETINOIC ACID PATHWAYS - FROM MOLECULAR-BIOLOGY TO CLINICAL-APPLICATIONS", Leukemia & lymphoma, 30(1-2), 1998, pp. 11
59. Heuser, M; van der Kuip, H; Falini, B; Peschel, C; Huber, C; Fischer, T
    Induction of the pro-myelocytic leukaemia gene by type I and type II interferons
    MEDIATORS OF INFLAMMATION
    
    M. Heuser et al., "Induction of the pro-myelocytic leukaemia gene by type I and type II interferons", MEDIAT INFL, 7(5), 1998, pp. 319-325
60. GIVOL I; GIVOL D; HUGHES SH
    OVEREXPRESSION OF P21(WAF1 CIP1) ARRESTS THE GROWTH OF CHICKEN-EMBRYOFIBROBLASTS THAT OVEREXPRESS E2F1/
    Oncogene
    
    I. Givol et al., "OVEREXPRESSION OF P21(WAF1 CIP1) ARRESTS THE GROWTH OF CHICKEN-EMBRYOFIBROBLASTS THAT OVEREXPRESS E2F1/", Oncogene, 16(24), 1998, pp. 3115-3122
61. HABIB AA; GULCHER JR; HOGNASON T; ZHENG LY; STEFANSSON K
    THE OMGP GENE, A 2ND-GROWTH SUPPRESSOR WITHIN THE NF1 GENE
    Oncogene
    
    A.A. Habib et al., "THE OMGP GENE, A 2ND-GROWTH SUPPRESSOR WITHIN THE NF1 GENE", Oncogene, 16(12), 1998, pp. 1525-1531
62. WAGNER P; FUCHS A; GOTZ C; NASTAINCZYK W; MONTENARH M
    FINE MAPPING AND REGULATION OF THE ASSOCIATION OF P53 WITH P34(CDC2)
    Oncogene
    
    P. Wagner et al., "FINE MAPPING AND REGULATION OF THE ASSOCIATION OF P53 WITH P34(CDC2)", Oncogene, 16(1), 1998, pp. 105-111
63. Tanimoto, A; Chen, H; Kao, CY; Moran, E; Sasaguri, Y; Padmanabhan, R
    Transactivation of the human cdc2 promoter by adenovirus E1A in cycling cells is mediated by induction of a 110-kDa CCAAT-box-binding factor
    ONCOGENE
    
    A. Tanimoto et al., "Transactivation of the human cdc2 promoter by adenovirus E1A in cycling cells is mediated by induction of a 110-kDa CCAAT-box-binding factor", ONCOGENE, 17(24), 1998, pp. 3103-3114
64. VINTERS HV; KERFOOT C; CATANIA M; EMELIN JK; ROPER SN; DECLUE JE
    TUBEROUS SCLEROSIS-RELATED GENE-EXPRESSION IN NORMAL AND DYSPLASTIC BRAIN
    Epilepsy research
    
    H.V. Vinters et al., "TUBEROUS SCLEROSIS-RELATED GENE-EXPRESSION IN NORMAL AND DYSPLASTIC BRAIN", Epilepsy research, 32(1-2), 1998, pp. 12-23
65. TONG JH; FANT X; DUPREZ E; BENOIT G; UPHOFF CC; DREXLER HG; PLA JC; LOFVENBERG E; LANOTTE M
    EXPRESSION PATTERNS OF THE JEM-1 GENE IN NORMAL AND TUMOR-CELLS - UBIQUITY CONTRASTING WITH A FAINT, BUT RETINOID-INDUCED, MESSENGER-RNA EXPRESSION IN PROMYELOCYTIC NB4 CELLS
    Leukemia
    
    J.H. Tong et al., "EXPRESSION PATTERNS OF THE JEM-1 GENE IN NORMAL AND TUMOR-CELLS - UBIQUITY CONTRASTING WITH A FAINT, BUT RETINOID-INDUCED, MESSENGER-RNA EXPRESSION IN PROMYELOCYTIC NB4 CELLS", Leukemia, 12(11), 1998, pp. 1733-1740
66. AHN JH; BRIGNOLE EJ; HAYWARD GS
    DISRUPTION OF PML SUBNUCLEAR DOMAINS BY THE ACIDIC IE1 PROTEIN OF HUMAN CYTOMEGALOVIRUS IS MEDIATED THROUGH INTERACTION WITH PML AND MAY MODULATE A RING FINGER-DEPENDENT CRYPTIC TRANSACTIVATOR FUNCTION OF PML
    Molecular and cellular biology
    
    J.H. Ahn et al., "DISRUPTION OF PML SUBNUCLEAR DOMAINS BY THE ACIDIC IE1 PROTEIN OF HUMAN CYTOMEGALOVIRUS IS MEDIATED THROUGH INTERACTION WITH PML AND MAY MODULATE A RING FINGER-DEPENDENT CRYPTIC TRANSACTIVATOR FUNCTION OF PML", Molecular and cellular biology, 18(8), 1998, pp. 4899-4913
67. TANIMOTO A; KAO CY; CHANG CC; SASAGURI Y; PADMANABHAN R
    DEREGULATION OF CDC2 GENE-EXPRESSION CORRELATES WITH OVEREXPRESSION OF A 110 KDA CCAAT BOX-BINDING FACTOR IN TRANSFORMED-CELLS
    Carcinogenesis (New York. Print)
    
    A. Tanimoto et al., "DEREGULATION OF CDC2 GENE-EXPRESSION CORRELATES WITH OVEREXPRESSION OF A 110 KDA CCAAT BOX-BINDING FACTOR IN TRANSFORMED-CELLS", Carcinogenesis (New York. Print), 19(10), 1998, pp. 1735-1741
68. GRAND RJA; IBRAHIM AP; TAYLOR AMR; MILNER AE; GREGORY CD; GALLIMORE PH; TURNELL AS
    HUMAN-CELLS ARREST IN S-PHASE IN RESPONSE TO ADENOVIRUS-12-E1A
    Virology
    
    R.J.A. Grand et al., "HUMAN-CELLS ARREST IN S-PHASE IN RESPONSE TO ADENOVIRUS-12-E1A", Virology, 244(2), 1998, pp. 330-342
69. CHELBIALIX MK; QUIGNON F; PELICANO L; KOKEN MHM; DETHE H
    RESISTANCE TO VIRUS-INFECTION CONFERRED BY THE INTERFERON-INDUCED PROMYELOCYTIC LEUKEMIA PROTEIN
    Journal of virology
    
    M.K. Chelbialix et al., "RESISTANCE TO VIRUS-INFECTION CONFERRED BY THE INTERFERON-INDUCED PROMYELOCYTIC LEUKEMIA PROTEIN", Journal of virology, 72(2), 1998, pp. 1043-1051
70. ALI JBM; SEPP T; WARD S; GREEN AJ; YATES JRW
    MUTATIONS IN THE TSC1 GENE ACCOUNT FOR A MINORITY OF PATIENTS WITH TUBEROUS SCLEROSIS
    Journal of Medical Genetics
    
    J.B.M. Ali et al., "MUTATIONS IN THE TSC1 GENE ACCOUNT FOR A MINORITY OF PATIENTS WITH TUBEROUS SCLEROSIS", Journal of Medical Genetics, 35(12), 1998, pp. 969-972
71. MACKIE RM; ANDREW N; LANYON WG; CONNOR JM
    CDKN2A GERMLINE MUTATIONS IN UK PATIENTS WITH FAMILIAL MELANOMA AND MULTIPLE PRIMARY MELANOMAS
    Journal of investigative dermatology
    
    R.M. Mackie et al., "CDKN2A GERMLINE MUTATIONS IN UK PATIENTS WITH FAMILIAL MELANOMA AND MULTIPLE PRIMARY MELANOMAS", Journal of investigative dermatology, 111(2), 1998, pp. 269-272
72. WILKINSON GWG; KELLY C; SINCLAIR JH; RICKARDS C
    DISRUPTION OF PML-ASSOCIATED NUCLEAR-BODIES MEDIATED BY THE HUMAN CYTOMEGALOVIRUS MAJOR IMMEDIATE-EARLY GENE-PRODUCT
    Journal of General Virology
    
    G.W.G. Wilkinson et al., "DISRUPTION OF PML-ASSOCIATED NUCLEAR-BODIES MEDIATED BY THE HUMAN CYTOMEGALOVIRUS MAJOR IMMEDIATE-EARLY GENE-PRODUCT", Journal of General Virology, 79, 1998, pp. 1233-1245
73. PLANK TL; YEUNG RS; HENSKE EP
    HAMARTIN, THE PRODUCT OF THE TUBEROUS SCLEROSIS-1 (TSC1) GENE, INTERACTS WITH TUBERIN AND APPEARS TO BE LOCALIZED TO CYTOPLASMIC VESICLES
    Cancer research
    
    T.L. Plank et al., "HAMARTIN, THE PRODUCT OF THE TUBEROUS SCLEROSIS-1 (TSC1) GENE, INTERACTS WITH TUBERIN AND APPEARS TO BE LOCALIZED TO CYTOPLASMIC VESICLES", Cancer research, 58(21), 1998, pp. 4766-4770
74. DELGADO R; BOJORGE BD; ALBORESSAAVEDRA J
    ATYPICAL ANGIOMYOLIPOMA OF THE KIDNEY - A DISTINCT MORPHOLOGIC VARIANT THAT IS EASILY CONFUSED WITH A VARIETY OF MALIGNANT NEOPLASMS
    Cancer
    
    R. Delgado et al., "ATYPICAL ANGIOMYOLIPOMA OF THE KIDNEY - A DISTINCT MORPHOLOGIC VARIANT THAT IS EASILY CONFUSED WITH A VARIETY OF MALIGNANT NEOPLASMS", Cancer, 83(8), 1998, pp. 1581-1592
75. ALSALEEM T; WESSNER LL; SCHEITHAUER BW; PATTERSON K; ROACH ES; DREYER SJ; FUJIKAWA K; BJORNSSON J; BERNSTEIN J; HENSKE EP
    MALIGNANT-TUMORS OF THE KIDNEY, BRAIN, AND SOFT-TISSUES IN CHILDREN AND YOUNG-ADULTS WITH THE TUBEROUS SCLEROSIS COMPLEX
    Cancer
    
    T. Alsaleem et al., "MALIGNANT-TUMORS OF THE KIDNEY, BRAIN, AND SOFT-TISSUES IN CHILDREN AND YOUNG-ADULTS WITH THE TUBEROUS SCLEROSIS COMPLEX", Cancer, 83(10), 1998, pp. 2208-2216
76. GIANNI M; KOKEN MHM; CHELBIALIX MK; BENOIT G; LANOTTE M; CHEN Z; DETHE H
    COMBINED ARSENIC AND RETINOIC ACID TREATMENT ENHANCES DIFFERENTIATIONAND APOPTOSIS IN ARSENIC-RESISTANT NB4 CELLS
    Blood
    
    M. Gianni et al., "COMBINED ARSENIC AND RETINOIC ACID TREATMENT ENHANCES DIFFERENTIATIONAND APOPTOSIS IN ARSENIC-RESISTANT NB4 CELLS", Blood, 91(11), 1998, pp. 4300-4310
77. YOUNG JM; BURLEY MW; JEREMIAH SJ; JEGANATHAN D; EKONG R; OSBORNE JP; POVEY S
    A MUTATION SCREEN OF THE TSC1 GENE REVEALS 26 PROTEIN TRUNCATING MUTATIONS AND 1 SPLICE-SITE MUTATION IN A PANEL OF 79 TUBEROUS SCLEROSIS PATIENTS
    Annals of Human Genetics
    
    J.M. Young et al., "A MUTATION SCREEN OF THE TSC1 GENE REVEALS 26 PROTEIN TRUNCATING MUTATIONS AND 1 SPLICE-SITE MUTATION IN A PANEL OF 79 TUBEROUS SCLEROSIS PATIENTS", Annals of Human Genetics, 62, 1998, pp. 203-213
78. HODGES M; TISSOT C; HOWE K; GRIMWADE D; FREEMONT PS
    STRUCTURE, ORGANIZATION, AND DYNAMICS OF PROMYELOCYTIC LEUKEMIA PROTEIN NUCLEAR-BODIES
    American journal of human genetics
    
    M. Hodges et al., "STRUCTURE, ORGANIZATION, AND DYNAMICS OF PROMYELOCYTIC LEUKEMIA PROTEIN NUCLEAR-BODIES", American journal of human genetics, 63(2), 1998, pp. 297-304
79. SMOLAREK TA; WESSNER LL; MCCORMACK FX; MYLET JC; MENON AG; HENSKE EP
    EVIDENCE THAT LYMPHANGIOMYOMATOSIS IS CAUSED BY TSC2 MUTATIONS - CHROMOSOME 16P13 LOSS OF HETEROZYGOSITY IN ANGIOMYOLIPOMAS AND LYMPH-NODESFROM WOMEN WITH LYMPHANGIOMYOMATOSIS
    American journal of human genetics
    
    T.A. Smolarek et al., "EVIDENCE THAT LYMPHANGIOMYOMATOSIS IS CAUSED BY TSC2 MUTATIONS - CHROMOSOME 16P13 LOSS OF HETEROZYGOSITY IN ANGIOMYOLIPOMAS AND LYMPH-NODESFROM WOMEN WITH LYMPHANGIOMYOMATOSIS", American journal of human genetics, 62(4), 1998, pp. 810-815
80. JIANG WQ; RINGERTZ N
    ALTERED DISTRIBUTION OF THE PROMYELOCYTIC LEUKEMIA-ASSOCIATED PROTEINIS ASSOCIATED WITH CELLULAR SENESCENCE
    Cell growth & differentiation
    
    W.Q. Jiang e N. Ringertz, "ALTERED DISTRIBUTION OF THE PROMYELOCYTIC LEUKEMIA-ASSOCIATED PROTEINIS ASSOCIATED WITH CELLULAR SENESCENCE", Cell growth & differentiation, 8(5), 1997, pp. 513-522
81. KOENIG MG; STURM D; PROWALD A; ISSINGER OG; MONTENARH M
    INTERACTION OF P53 WITH PROTEIN-KINASE CK2 DURING SV40 INDUCED ENTRANCE OF QUIESCENT CELLS INTO THE CELL-CYCLE
    International journal of oncology
    
    M.G. Koenig et al., "INTERACTION OF P53 WITH PROTEIN-KINASE CK2 DURING SV40 INDUCED ENTRANCE OF QUIESCENT CELLS INTO THE CELL-CYCLE", International journal of oncology, 10(2), 1997, pp. 405-411
82. JOBERT S; BRAGADONILSSON E; SAMOLYK D; PEDESPAN JM; MARCHAL C; REICHERT S; MALLET J; PITIOT G
    DELETION OF 11 AMINO-ACIDS IN TUBERIN ASSOCIATED WITH SEVERE TUBEROUSSCLEROSIS PHENOTYPES - EVIDENCE FOR A NEW ESSENTIAL DOMAIN IN THE FIRST 3RD OF THE PROTEIN
    European journal of human genetics
    
    S. Jobert et al., "DELETION OF 11 AMINO-ACIDS IN TUBERIN ASSOCIATED WITH SEVERE TUBEROUSSCLEROSIS PHENOTYPES - EVIDENCE FOR A NEW ESSENTIAL DOMAIN IN THE FIRST 3RD OF THE PROTEIN", European journal of human genetics, 5(5), 1997, pp. 280-287
83. YATES JRW; VANBAKEL I; SEPP T; PAYNE SJ; WEBB DW; NEVIN NC; GREEN AJ
    FEMALE GERMLINE MOSAICISM IN TUBEROUS SCLEROSIS CONFIRMED BY MOLECULAR-GENETIC ANALYSIS
    Human molecular genetics
    
    J.R.W. Yates et al., "FEMALE GERMLINE MOSAICISM IN TUBEROUS SCLEROSIS CONFIRMED BY MOLECULAR-GENETIC ANALYSIS", Human molecular genetics, 6(13), 1997, pp. 2265-2269
84. PELICANO L; LI FS; SCHINDLER C; CHELBIALIX MK
    RETINOIC ACID ENHANCES THE EXPRESSION OF INTERFERON-INDUCED PROTEINS - EVIDENCE FOR MULTIPLE MECHANISMS OF ACTION
    Oncogene
    
    L. Pelicano et al., "RETINOIC ACID ENHANCES THE EXPRESSION OF INTERFERON-INDUCED PROTEINS - EVIDENCE FOR MULTIPLE MECHANISMS OF ACTION", Oncogene, 15(19), 1997, pp. 2349-2359
85. BANGA SS; KIM S; HUBBARD K; DASGUPTA T; JHA KK; PATSALIS P; HAUPTSCHEIN R; GAMBERI B; DALLAFAVERA R; KRAEMER P; OZER HL
    SEN6, A LOCUS FOR SV40-MEDIATED IMMORTALIZATION OF HUMAN-CELLS, MAPS TO 6Q26-27
    Oncogene
    
    S.S. Banga et al., "SEN6, A LOCUS FOR SV40-MEDIATED IMMORTALIZATION OF HUMAN-CELLS, MAPS TO 6Q26-27", Oncogene, 14(3), 1997, pp. 313-321
86. DAVID G; TERRIS B; MARCHIO A; LAVAU C; DEJEAN A
    THE ACUTE PROMYELOCYTIC LEUKEMIA PML-RAR-ALPHA PROTEIN INDUCES HEPATIC PRENEOPLASTIC AND NEOPLASTIC LESIONS IN TRANSGENIC MICE
    Oncogene
    
    G. David et al., "THE ACUTE PROMYELOCYTIC LEUKEMIA PML-RAR-ALPHA PROTEIN INDUCES HEPATIC PRENEOPLASTIC AND NEOPLASTIC LESIONS IN TRANSGENIC MICE", Oncogene, 14(13), 1997, pp. 1547-1554
87. DETHE H
    ARSENIC TRIOXIDE - AFTER RETINOIC ACID, A NEW ONCOGENE TARGETED TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    MS. Medecine sciences
    
    H. Dethe, "ARSENIC TRIOXIDE - AFTER RETINOIC ACID, A NEW ONCOGENE TARGETED TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA", MS. Medecine sciences, 13(6-7), 1997, pp. 867-871
88. QUIGNON F; CHEN Z; DETHE H
    RETINOIC ACID AND ARSENIC - TOWARDS ONCOGENE-TARGETED TREATMENTS OF ACUTE PROMYELOCYTIC LEUKEMIA
    Biochimica et biophysica acta, CR. Reviews on cancer
    
    F. Quignon et al., "RETINOIC ACID AND ARSENIC - TOWARDS ONCOGENE-TARGETED TREATMENTS OF ACUTE PROMYELOCYTIC LEUKEMIA", Biochimica et biophysica acta, CR. Reviews on cancer, 1333(3), 1997, pp. 53-61
89. SZOSTECKI C; GULDNER HH; WILL H
    AUTOANTIBODIES AGAINST NUCLEAR DOTS IN PRIMARY BILIARY-CIRRHOSIS
    Seminars in liver disease
    
    C. Szostecki et al., "AUTOANTIBODIES AGAINST NUCLEAR DOTS IN PRIMARY BILIARY-CIRRHOSIS", Seminars in liver disease, 17(1), 1997, pp. 71-78
90. CHEN Z; WANG ZY; CHEN SJ
    ACUTE PROMYELOCYTIC LEUKEMIA - CELLULAR AND MOLECULAR-BASIS OF DIFFERENTIATION AND APOPTOSIS
    Pharmacology & therapeutics
    
    Z. Chen et al., "ACUTE PROMYELOCYTIC LEUKEMIA - CELLULAR AND MOLECULAR-BASIS OF DIFFERENTIATION AND APOPTOSIS", Pharmacology & therapeutics, 76(1-3), 1997, pp. 141-149
91. MU ZM; LE XF; VALLIAN S; GLASSMAN AB; CHANG KS
    STABLE OVEREXPRESSION OF PML ALTERS REGULATION OF CELL-CYCLE PROGRESSION IN HELA-CELLS
    Carcinogenesis
    
    Z.M. Mu et al., "STABLE OVEREXPRESSION OF PML ALTERS REGULATION OF CELL-CYCLE PROGRESSION IN HELA-CELLS", Carcinogenesis, 18(11), 1997, pp. 2063-2069
92. ZHU J; KOKEN MHM; QUIGNON F; CHELBIALIX MK; DEGOS L; WANG ZY; CHEN Z; DETHE H
    ARSENIC-INDUCED PML TARGETING ONTO NUCLEAR-BODIES - IMPLICATIONS FOR THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    J. Zhu et al., "ARSENIC-INDUCED PML TARGETING ONTO NUCLEAR-BODIES - IMPLICATIONS FOR THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA", Proceedings of the National Academy of Sciences of the United Statesof America, 94(8), 1997, pp. 3978-3983
93. FERRUCCI PF; GRIGNANI F; PEARSON M; FAGIOLI M; NICOLETTI I; PELICCI PG
    CELL-DEATH INDUCTION BY THE ACUTE PROMYELOCYTIC LEUKEMIA-SPECIFIC PMLRAR-ALPHA FUSION PROTEIN/
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    P.F. Ferrucci et al., "CELL-DEATH INDUCTION BY THE ACUTE PROMYELOCYTIC LEUKEMIA-SPECIFIC PMLRAR-ALPHA FUSION PROTEIN/", Proceedings of the National Academy of Sciences of the United Statesof America, 94(20), 1997, pp. 10901-10906
94. KOKEN MHM; REID A; QUIGNON F; CHELBIALIX MK; DAVIES JM; KABAROWSKI JHS; ZHU J; DONG S; CHEN SJ; CHEN Z; TAN CC; LICHT J; WAXMAN S; DETHE H; ZELENT A
    LEUKEMIA-ASSOCIATED RETINOIC ACID RECEPTOR-ALPHA FUSION PARTNERS, PMLAND PLZF, HETERODIMERIZE AND COLOCALIZE TO NUCLEAR-BODIES
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    M.H.M. Koken et al., "LEUKEMIA-ASSOCIATED RETINOIC ACID RECEPTOR-ALPHA FUSION PARTNERS, PMLAND PLZF, HETERODIMERIZE AND COLOCALIZE TO NUCLEAR-BODIES", Proceedings of the National Academy of Sciences of the United Statesof America, 94(19), 1997, pp. 10255-10260
95. HE LZ; TRIBIOLI C; RIVI R; PERUZZI D; PELICCI PG; SOARES V; CATTORETTI G; PANDOLFI PP
    ACUTE-LEUKEMIA WITH PROMYELOCYTIC FEATURES IN PML RAR-ALPHA TRANSGENIC MICE/
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    L.Z. He et al., "ACUTE-LEUKEMIA WITH PROMYELOCYTIC FEATURES IN PML RAR-ALPHA TRANSGENIC MICE/", Proceedings of the National Academy of Sciences of the United Statesof America, 94(10), 1997, pp. 5302-5307
96. AHN JH; HAYWARD GS
    THE MAJOR IMMEDIATE-EARLY PROTEINS IE1 AND IE2 OF HUMAN CYTOMEGALOVIRUS COLOCALIZE WITH AND DISRUPT PML-ASSCCIATED NUCLEAR-BODIES AT VERY EARLY TIMES IN INFECTED PERMISSIVE CELLS
    Journal of virology
    
    J.H. Ahn e G.S. Hayward, "THE MAJOR IMMEDIATE-EARLY PROTEINS IE1 AND IE2 OF HUMAN CYTOMEGALOVIRUS COLOCALIZE WITH AND DISRUPT PML-ASSCCIATED NUCLEAR-BODIES AT VERY EARLY TIMES IN INFECTED PERMISSIVE CELLS", Journal of virology, 71(6), 1997, pp. 4599-4613
97. LUKONIS CJ; WELLER SK
    FORMATION OF HERPES-SIMPLEX VIRUS TYPE-1 REPLICATION COMPARTMENTS BY TRANSFECTION - REQUIREMENTS AND LOCALIZATION TO NUCLEAR DOMAIN-10
    Journal of virology
    
    C.J. Lukonis e S.K. Weller, "FORMATION OF HERPES-SIMPLEX VIRUS TYPE-1 REPLICATION COMPARTMENTS BY TRANSFECTION - REQUIREMENTS AND LOCALIZATION TO NUCLEAR DOMAIN-10", Journal of virology, 71(3), 1997, pp. 2390-2399
98. GONGORA C; DAVID G; PINTARD L; TISSOT C; HUA TD; DEJEAN A; MECHTI N
    MOLECULAR-CLONING OF A NEW INTERFERON-INDUCED PML NUCLEAR BODY-ASSOCIATED PROTEIN
    The Journal of biological chemistry
    
    C. Gongora et al., "MOLECULAR-CLONING OF A NEW INTERFERON-INDUCED PML NUCLEAR BODY-ASSOCIATED PROTEIN", The Journal of biological chemistry, 272(31), 1997, pp. 19457-19463
99. PROWALD A; SCHUSTER N; MONTENARH M
    REGULATION OF THE DNA-BINDING OF P53 BY ITS INTERACTION WITH PROTEIN-KINASE CK2
    FEBS letters
    
    A. Prowald et al., "REGULATION OF THE DNA-BINDING OF P53 BY ITS INTERACTION WITH PROTEIN-KINASE CK2", FEBS letters, 408(1), 1997, pp. 99-104
100. VALLIAN S; GAKEN JA; TRAYNER ID; GINGOLD EB; KOUZARIDES T; CHANG KS; FARZANEH F
     TRANSCRIPTIONAL REPRESSION BY THE PROMYELOCYTIC LEUKEMIA PROTEIN, PML
     Experimental cell research
     
     S. Vallian et al., "TRANSCRIPTIONAL REPRESSION BY THE PROMYELOCYTIC LEUKEMIA PROTEIN, PML", Experimental cell research, 237(2), 1997, pp. 371-382